The domain within your query sequence starts at position 1061 and ends at position 1527; the E-value for the GDE_C domain shown below is 1.1e-137.
PSLLDVPCRLNEITKEKEQCCASLAAGLPHFSSGLFRCWGRDTFIALRGMLLVTGRYLEA RNIILAFASTLRHGLIPNLLGEGTYARYNCRDAVWWWLQCIQDYCRTVPNGLDILKCPVS RMYPTDDSAPLPAGTLDQPLFEVIQEAMQRHMQGIQFRERNAGPQIDRNMKDEGFNITAG IDEETGFVYGGNRFNCGTWMDKMGESDRARNRGIPATPRDGSAVEIVGLCKSAVRWLLEL SKKNIFPYHEVRVKRHGKVVAVSYDEWNRKIQNNFEKLFHVSEDPSDPNEKHPNLVHKRG IYKDSYGASSPWCDYQLRPNFTIAMVVAPELFTAEKAWKALEIAEKKLLGPLGMKTLDPD DMVYCGVYDNALDNDNYNLARGFNYHQGPEWLWPIGYFLRAKLYFSKMMGPETAAKTVFL VKNVLSRHYVHLERSPWKGLPELTNENGQYCPFSCETQAWSMAVVLE
GDE_C |
---|
PFAM accession number: | PF06202 |
---|---|
Interpro abstract (IPR032790): | This entry represents the C-terminal domain of the glycogen debranching enzyme AGL. AGL is a multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation [ (PUBMED:21585652) ]. This a glucosidase domain. Mutations in this region disrupt the glucosidase activity [ (PUBMED:11375985) ]. |
This is a PFAM domain. For full annotation and more information, please see the PFAM entry GDE_C